{"title":"Combination Treatment of Natural Compounds and Integrative Therapies for Mild Traumatic Brain Injury","authors":"A. Olivera, Heather L. Rusch, J. Gill","doi":"10.4172/2168-975X.1000198","DOIUrl":null,"url":null,"abstract":"Each year millions of Americans seek acute care for mild traumatic brain injury (mTBI), which is often associated with a range of debilitating sequelae including cognitive, behavioral, emotional, and motor deficits [1]. New evidence indicates that neuroinflammatory responses, excitotoxicity, and oxidative stress may directly contribute to the emergence and maintenance of these chronic postconcussive symptoms (PCS) [2]. In instances of traumatic axonal injury, accumulations of tau and amyloid peptides can form, which may be an early sign of neurodegeneration linked to dementia and Alzheimer’s disease [3]. Given the multiple mechanisms underlying PCS, it is reasonable to suggest that successfully preventing or attenuating PCS cannot be accomplished via pharmacological agents with a single mode of action. Herein, we propose that a combination of natural compounds and intergrative therapies with systemic effect may provide a comprehensive treatment strategy for addressing the secondary injury following mTBI.","PeriodicalId":9146,"journal":{"name":"Brain disorders & therapy","volume":"141 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain disorders & therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2168-975X.1000198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Each year millions of Americans seek acute care for mild traumatic brain injury (mTBI), which is often associated with a range of debilitating sequelae including cognitive, behavioral, emotional, and motor deficits [1]. New evidence indicates that neuroinflammatory responses, excitotoxicity, and oxidative stress may directly contribute to the emergence and maintenance of these chronic postconcussive symptoms (PCS) [2]. In instances of traumatic axonal injury, accumulations of tau and amyloid peptides can form, which may be an early sign of neurodegeneration linked to dementia and Alzheimer’s disease [3]. Given the multiple mechanisms underlying PCS, it is reasonable to suggest that successfully preventing or attenuating PCS cannot be accomplished via pharmacological agents with a single mode of action. Herein, we propose that a combination of natural compounds and intergrative therapies with systemic effect may provide a comprehensive treatment strategy for addressing the secondary injury following mTBI.